Home
Contact
Publications
Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer
3rd March 2017
Nitin Jain
Enadenotucirev Preclinical
Full Text
Share this Story
Facebook
Twitter
LinkedIn
Reddit
Digg
Delicious
Google++
E-Mail+
About the Author
Comments are closed.
Prev Post
Next Post
Filter Publications
Enadenotucirev Preclinical
Enadenotucirev Clinical
T-SIGn
Reviews
See All Publications
© Copyright 2021 PsiOxus Therapeutics
RSS
Back to Top
About
Vision & Strategy
People & Investors
Partnering
Recruitment Opportunities
Awards & Achievements
Pipeline
Pipeline
Enadenotucirev
T-SIGn Platform
NG-348
NG-350A
NG-641
Publications
Clinical Trials
News & Events
PsiOxus in the News
Contact
Menu
Comments are closed.